V+PSF-M for Tobacco Cessation in HIV Care in India

Summary

The goal of this research study is to test an intervention to help quit tobacco use in participants with Human Immunodeficiency Virus (HIV). The study interventions used in this research study are: * Positively Smoke Free - Mobile (PSF-M) (mobile behavioral program) * Varenicline (or Chantix, apovarenicline, Champix or Nocrav)

Timeline

Start

2024-01-02

Primary completion

2026-07-22

Completion

2026-07-22

Publications

• Malpeddi T, Poongulali S, Shuter J, Rigotti NA, An LC, Kumarasamy N, Reddy KP, Shergina E, Colborn K, Faith B, Sierra YL, Kruse GR. Protocol for the Mobile behavioral support plus varenicline for tobacco cessation among people living with HIV in India (MoVIe): A hybrid implementation-effectiveness randomized trial. Contemp Clin Trials. 2026 Jan;160:108179. doi: 10.1016/j.cct.2025.108179. Epub 2025 Dec 4.

Drugs

Indications